Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-053867
Filing Date
2025-04-14
Accepted
2025-04-14 19:26:34
Documents
1
Period of Report
2025-04-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4987
  Complete submission text file 0000950170-25-053867.txt   6402
Mailing Address 11119 NORTH TORREY PINES RD #200 LA JOLLA CA 92037
Business Address
FOEHR MATTHEW W (Reporting) CIK: 0001237556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 25837206

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)